Viridian Therapeutics
VRDN
$13.45
Share price
-8.07%
Change (1 day)
-41.29%
Change (1 year)
Categories
Viridian Therapeutics (VRDN) - Total debt
Total debt on the balance sheet as of December 2023 : $21.04 M
According to Viridian Therapeutics's latest financial reports the company's total debt is $21.04 M. A company’s total debt is the sum of all current and non-current debts.
Viridian Therapeutics - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $21.04 M | 300.3% |
| 2022-12-31 | $5.25 M | 911.15% |
| 2021-12-31 | $0.52 M | 14.29% |
| 2020-12-31 | $0.45 M | -94.52% |
| 2019-12-31 | $8.3 M | -19.36% |
| 2018-12-31 | $10.29 M | 3.79% |
| 2017-12-31 | $9.92 M | 849.47% |
| 2016-12-31 | $1.04 M | -5.43% |
| 2015-12-31 | $1.1 M | 1281.25% |
| 2014-12-31 | $0.08 M | -99.7% |
| 2013-12-31 | $26.61 M | 17.59% |
| 2012-12-31 | $22.62 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | -86.93% | 🇺🇸 USA |